382 / 1498
Overall Survival
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0
12
24
36
48
60
72
Time [months]
p-value
60 months difference
A
vs.
B
: 0.02
3.3%
97.5%-CI: [ 0.2%, 6.5%]
A
vs.
C
: 0.07
2.6%
[-0.6%, 5.9%]
C
vs.
B
: 0.6
0.7%
[-2.1%, 3.5%]
HD15 in advanced HL
Overall Survival (OS @ 5yrs)
A: 91.9%
B: 95.3%
C: 94.5%
Engert A et al, Lancet 2012